A Nigerian scientist has won the BNP Paribas Group Deep Tech Global Challenge 2019.
Adebayo Alonge, the CEO and co-founder of RxAll, won the fiercely fought competition that carried a grand price of over €100,000 for inventing handheld nanoscanners that can detect fake drugs.
Alonge, who himself had been a victim of fake drugs, is the first African to win this competition. He competed alongside 4500 DeepTech Startups from all over the world to win the coverted prize.
Alonge received most of his science education in Nigeria. “When I meet other scientists and innovators across the world and I tell them this, I am often amused at their surprise” he recently said in an interview.
“Yes my business education was at Yale but my science education from high school (at King’s College Lagos) to pharmacy school (at the University of Ibadan) was in Africa. That I can hold my own internationally with the best scientists and deepTech innovators in the world is testament to the quality of local education and talent in Africa, when supported with the right resources”
Adebayo is a pharmacist and market development professional with a business degree from Yale. He has 8+years in market development and strategy consulting across Africa working with BCG, BASF, Roche and Sanofi.
The award, under the umbrella of Hello Tomorrow Global Challenge, is a renowned global startup competition designed specifically to address the needs of deeptech entrepreneurs across several different industries and technologies. The Hello Tomorrow Global Challenge gives scientists and deeptech entrepreneurs from across the world a platform for their research and projects, providing equity-free prize money as well as other funding opportunities, global visibility and connections with key players in the deeptech innovation network.